StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3030% above fair value
$536.45+2.25 (+0.42%)

Close on Nov 18, 2026Market cap $135.97BP/E 31.2Yield –

Vertex Pharmaceuticals Total consolidated revenues by Quarter

Total consolidated revenues ($M) ($M)

Vertex Pharmaceuticals Total consolidated revenues: $3,334M in Q2 2026, up 12.5% from a year earlier. That is the highest of the 70 quarters on record here.

Latest, Q2 2026
3,334
Period ended Jun 30, 2026
Change on a year earlier
+12.5%
2,965 in Q2 2025
History
70 quarters
Since Q1 2009
Sources
45
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations & Revenue Note.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal consolidated revenues ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20263,334+12.5%Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 20262,987+7.8%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 20253,190+9.5%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20253,076+11.0%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 20252,965+12.1%Form 10-Q (filed 2026-08-04) ↗
Q1 2025Mar 31, 20252,770+3.0%Form 10-Q (filed 2026-05-05) ↗
Q4 2024Dec 31, 20242,912+15.7%Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 20242,772+11.6%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 20242,646+6.1%Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 20242,691+13.3%Form 10-Q (filed 2025-05-06) ↗
Q4 2023Dec 31, 20232,518+9.3%Form 10-K (filed 2026-02-13) ↗
Q3 2023Sep 30, 20232,484+6.4%Form 10-Q (filed 2024-11-05) ↗
Q2 2023Jun 30, 20232,493+13.5%Form 10-Q (filed 2024-08-02) ↗
Q1 2023Mar 31, 20232,375+13.2%Form 10-Q (filed 2024-05-07) ↗
Q4 2022Dec 31, 20222,303+11.1%Form 10-K (filed 2025-02-13) ↗
Q3 2022Sep 30, 20222,334+17.7%Form 10-Q (filed 2023-11-07) ↗

Breakdown

What makes up total consolidated revenues

Cite this data

StockData. (2026). Vertex Pharmaceuticals Total consolidated revenues ($M), quarterly Q1 2009–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rev-total

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.

See a number that looks wrong?